Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Mark Tapsak, PhD

Mark Tapsak, PhD, Assistant Professor, BLOOMSBURG UNIVERSITY OF PENNSYLVANIA INCAssistant Professor
BLOOMSBURG UNIVERSITY OF PENNSYLVANIA INC
Member of the Healthcare Council

Mark Tapsak, PhD, is an Assistant Professor of Chemistry at Bloomsburg University of Pennsylvania. Prior to joining Bloomsburg University, he was a Senior Scientist at DexCom in San Diego, CA. Dr. Tapsak has also worked for Medtronic in Minneapolis, MN. His academic experience centers on polymer synthesis, polymer characterization and analytical chemistry. Dr. Tapsak's industry experience utilized his polymer chemistry training in medical product innovation, project management, technology transfer, and intellectual property strategies. He holds 13 US patents on medical devices and materials. He also is listed on more than 30 patent applications still under review in this field. (This is me - Update Profile)


Employment History
2004 - present Assistant Professor
BLOOMSBURG UNIVERSITY OF PENNSYLVANIA INC
2000 - 2004 Senior Scientist
DEXCOM, INC.
1996 - 2000 Senior Polymer Chemist
Medtronic Global

GLG Study Groups with Mark Tapsak, PhD(?)

Study Group Name Members
Users of Mass Spectrometers in the U.S. 69

GLG NewsSM Analyses by Mark Tapsak, PhD(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Industry leaders need to work with the US Patent and Trademark office to keep US patents strong | 04-24-2008
Analysis of: Federal Court Sides With GlaxoSmithKline, Strikes Down Rules Issued by Patent Office | biz.yahoo.com
Author: Mark Tapsak, PhD, Assistant Professor, BLOOMSBURG UNIVERSITY OF PENNSYLVANIA INC

The USPTO is facing an epidemic amount of frivolous patents.  This degrades their ability to review strong and potentially important patents in a timely manner.  Although this particular change was struck down in Federal court, industry leaders need to work with the USPTO in order...

CooperVision enters US market with Avaira™ two-week silicone hydrogel contact lenses | 04-16-2008
Analysis of: CooperVision Introduces Avaira™ Two-Week Silicone Hydrogel Contact Lenses | www.coopervision.com
Author: Mark Tapsak, PhD, Assistant Professor, BLOOMSBURG UNIVERSITY OF PENNSYLVANIA INC

I’m not so sure that this is a leap forward for CooperVision.  After long delays for the release of the Biofinity lens, a two-week version has just been released.  The material properties are reportedly “nice”, but certainly scaled back from what was reportedly achieved with Comfilcon...

DexCom Makes Progress Towards Easier Glucose Monitoring | 11-19-2007
Analysis of: Dexcom says gets FDA OK to calibrate glucose monitoring system | www.reuters.com
Author: Mark Tapsak, PhD, Assistant Professor, BLOOMSBURG UNIVERSITY OF PENNSYLVANIA INC

It's not easy being small, especially in the world of medical devices. Big players leverage branding, large sales forces and deep R&D organizations when they bring technologies to market. Unfortunately, most products are incremental improvements at best. Rarely does the conservative healthcare market benefit...

All plastics are not created equal, choose wisely young biomedical engineer | 10-22-2007
Analysis of: Materials: Adding Sustainability to Product Development | www.devicelink.com
Author: Mark Tapsak, PhD, Assistant Professor, BLOOMSBURG UNIVERSITY OF PENNSYLVANIA INC

Material choices for the designer of medical devices are traditionally limited to those that already enjoy a proven track record. The use of truly new materials in a medical device is not only risky for the device manufacturer, but also for the material manufacturer. In particular, tissue contacting...

GLG InstituteSM Seminars with Mark Tapsak, PhD(?)

 
Mark Tapsak, PhD has not participated in any GLGi Seminars.
View all GLG InstituteSM Seminars in Healthcare

Request a project with Mark Tapsak, PhD









Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics